Investors / United States / Altamont Pharmaceutical Holdings
Altamont Pharmaceutical Holdings
Investor · Dallas, TX, United States · North America
Altamont is a biotech investment firm that invests in undervalued small to mid-cap publicly traded biotech companies. It also incubates startups by licensing technologies from research institutes and universities and partnering with large pharma companies.
Invests inHealthcare & Biotech
In its own wordsbiotechpublic marketsincubationtherapeuticslife sciencespharma
Your fit with Altamont Pharmaceutical Holdings
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsAltamont Pharmaceutical Holdings lists 49 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 86% of its companies are based in United States. It invests most often alongside Foresite Capital, Avoro Capital Advisors and Frazier Life Sciences.
No funding round on record names Altamont Pharmaceutical Holdings yet, so the figures come from its portfolio page.
Round figures show recent activity, not Altamont Pharmaceutical Holdings' whole history. Rounds on record name 0 companies; its own site lists 49. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 83th | 49 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 84th | 6 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers4184%
- No longer answers00%
- Points to another company816%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Foresite Capital
Compare Altamont Pharmaceutical Holdings head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
49 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
| AC Immune SA is a clinical-stage biopharmaceutical company developing precision medicine for neurodegenerative diseases | Healthcare & Biotech | Portfolio page | ||
| Akero Therapeutics is pioneering novel therapies to transform the lives of people living with serious metabolic diseases | Healthcare & Biotech | Portfolio page | ||
| Alkermes develops medicines for psychiatric and neurological disorders | Healthcare & Biotech | Portfolio page | ||
| Alumis Inc is focused on immune-mediated disease therapies | Healthcare & Biotech | Portfolio page | ||
| Amygdala Neurosciences is a biopharmaceutical company that invents and develops medicines to treat substance use disorders | Healthcare & Biotech | Portfolio page | ||
| AnaptysBio manages financial collaborations with pharmaceutical companies | Healthcare & Biotech | Portfolio page | ||
| Ardelyx delivers first-in-class medicines to patients with unmet medical needs. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| The company develops medicines through novel therapeutic approaches that improve the lives of people with serious brain disorders. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Celldex Therapeutics develops antibody-based immunotherapies for various diseases. | Healthcare & Biotech | Portfolio page | ||
| Cessation is developing a novel antibody therapy to prevent overdose related to fentanyl and fentanyl analogs | Healthcare & Biotech | Portfolio page | ||
| Compass Therapeutics is developing product candidates designed to optimize critical components required for an effective anti-tumor response to cancer | Healthcare & Biotech | Portfolio page | ||
| Corvus is a clinical-stage biopharmaceutical company developing novel therapies with the potential to significantly improve the treatment of immune diseases and cancer. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| CytomX is a clinical-stage biopharmaceutical company researching and developing therapies to treat cancer. | Healthcare & Biotech | Portfolio page | ||
| Deciphera develops and delivers novel, innovative medicines to treat patients across oncology, immunology and inflammation, and neurology | Healthcare & Biotech | Portfolio page | ||
| Dialectic Therapeutics is a biotechnology company dedicated to the development of unique, impactful anti-cancer drugs that effectively treat patients with few to no other options. | Healthcare & Biotech | Portfolio page | ||
| Fate Therapeutics is developing clinical drug candidates for the treatment of autoimmune diseases and cancer, with cell products designed to overcome key limitations inherent to the manufacture, development and commercialization of other cell therapies | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- altamontpharma.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 49
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Altamont Pharmaceutical Holdings' profile as data
Pull Altamont Pharmaceutical Holdings' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/altamontpharma.com
# also
GET /v1/firms/altamontpharma.com/portfolio
GET /v1/firms/altamontpharma.com/coinvestors
GET /v1/firms/altamontpharma.com/news